Cargando…
Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077517/ https://www.ncbi.nlm.nih.gov/pubmed/35535132 http://dx.doi.org/10.1016/j.xinn.2022.100249 |
| _version_ | 1784702134449602560 |
|---|---|
| author | Shen, Lin |
| author_facet | Shen, Lin |
| author_sort | Shen, Lin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9077517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90775172022-05-08 Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges Shen, Lin Innovation (Camb) Editorial Elsevier 2022-04-18 /pmc/articles/PMC9077517/ /pubmed/35535132 http://dx.doi.org/10.1016/j.xinn.2022.100249 Text en © 2022. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Shen, Lin Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title | Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title_full | Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title_fullStr | Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title_full_unstemmed | Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title_short | Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges |
| title_sort | anticancer drug r&d of gastrointestinal cancer in china: current landscape and challenges |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077517/ https://www.ncbi.nlm.nih.gov/pubmed/35535132 http://dx.doi.org/10.1016/j.xinn.2022.100249 |
| work_keys_str_mv | AT shenlin anticancerdrugrdofgastrointestinalcancerinchinacurrentlandscapeandchallenges |